In summary, our results indicate that survivin/BIRC5 and XIAP are differently expressed in MPNs and YM155 has multiple antineoplastic effects on MPN cell models, suggesting that inhibitors of apoptosis proteins may be a point of pharmacological intervention for the treatment of these diseases. This evidence concerns the gene BIRC5 and myeloproliferative disorder.